Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Salt Lake City, Utah 84108


The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compare quadriceps strength recovery over time and exploratory variables between the groups.


Inclusion Criteria: - ≥ 40 Years Old - Scheduled for Primary Total Knee Arthroplasty Exclusion Criteria: - Opiate Tolerant (≥60mg/day oral morphine/equivalent for ≥1 week) - Neuromuscular deficit affecting the lower limbs - Peripheral neuropathy - Radiculopathy/Sciatica - Known allergy or intolerance to Bupivacaine or Ropivacaine - Hepatic Disease - Renal Disease/Patients needing Dialysis - Planned unicompartmental knee replacement - Less than 90 degree of knee flexion preoperatively. - Patients who lack the capacity to consent or are unwilling to do so - At the discretion of the PI, patients who may have difficulty complying with standard of care (SOC) followup may also be excluded



Primary Contact:

Principal Investigator
Christopher Pelt, M.D.
University of Utah

Backup Contact:


Location Contact:

Salt Lake City, Utah 84108
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.